Manufacturing Costs For Large Molecule Development Work

In Q3 2020, ISR asked 25 respondents to allocate the costs of development work and clinical trial materials for outsourced biologics. The data show that Drug Product Manufacturing captures the largest proportion of expenditure at this stage, followed by API Manufacturing, Process Development and Clinical Supplies. To learn more about Large Molecule Costs by Activity, including how costs are allocated for commercial manufacturing, follow the link to the CDMO Outsourcing Models report preview.